Literature DB >> 11093802

Importance of histidine residues for the function of the human liver UDP-glucuronosyltransferase UGT1A6: evidence for the catalytic role of histidine 370.

M Ouzzine1, L Antonio, B Burchell, P Netter, S Fournel-Gigleux, J Magdalou.   

Abstract

The human UDP-glucuronosyltransferase isoform UGT1A6 catalyzes the nucleophilic attack of phenolic xenobiotics on glucuronic acid, leading to the formation of water-soluble glucuronides. Based on the irreversible inhibition of the enzyme activity by the histidyl-selective reagent diethyl pyrocarbonate (DEPC), histidine was suggested to play a key role in the glucuronidation reaction. Therefore, the role of four strictly conserved histidine residues (His38, His361, His370, and His485) in the glucuronidation of 4-methylumbelliferone, as reporter substrate, was examined using site-directed mutagenesis. For this purpose, stable heterologous expression of wild-type and mutant UGT1A6 was achieved in the yeast Pichia pastoris. Replacement of histidine residues by alanine or glutamine led to fully inactive H38A, H38Q, and H485A mutants. Substitution of His361 by alanine affected the interaction of the enzyme with the cosubstrate, as indicated by a 4-fold increase in the K(m) value toward UDP-glucuronic acid. Interestingly, H370A mutant presented a severely impaired catalytic efficiency (with a V(max) value approximately 5% that of the wild-type), whereas conservative substitution of His370 by glutamine (H370Q) led to a significant restoration of activity. Whereas H361A was inactivated by DEPC as the wild-type enzyme, this chemical reagent only produced a minor effect on either H370Q or H370A mutant, providing evidence that His370 is probably the reactive histidine residue targeted by DEPC. The dramatic changes in catalytic efficiency on substitution of His370 by alanine and the ability of glutamine to function in place of histidine along with a weak sensitivity of these mutants to DEPC strongly suggest that His370 plays a catalytic role in the glucuronidation reaction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11093802     DOI: 10.1124/mol.58.6.1609

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  6 in total

1.  Phylogenetic and mutational analyses reveal key residues for UDP-glucuronic acid binding and activity of beta1,3-glucuronosyltransferase I (GlcAT-I).

Authors:  Magali Fondeur-Gelinotte; Virginie Lattard; Rafael Oriol; Rosella Mollicone; Jean-Claude Jacquinet; Guillermo Mulliert; Sandrine Gulberti; Patrick Netter; Jacques Magdalou; Mohamed Ouzzine; Sylvie Fournel-Gigleux
Journal:  Protein Sci       Date:  2006-07       Impact factor: 6.725

2.  Enzyme Kinetics of Uridine Diphosphate Glucuronosyltransferases (UGTs).

Authors:  Jin Zhou; Upendra A Argikar; John O Miners
Journal:  Methods Mol Biol       Date:  2021

3.  Faulty initiation of proteoglycan synthesis causes cardiac and joint defects.

Authors:  Sevjidmaa Baasanjav; Lihadh Al-Gazali; Taishi Hashiguchi; Shuji Mizumoto; Bjoern Fischer; Denise Horn; Dominik Seelow; Bassam R Ali; Samir A A Aziz; Ruth Langer; Ahmed A H Saleh; Christian Becker; Gudrun Nürnberg; Vincent Cantagrel; Joseph G Gleeson; Delphine Gomez; Jean-Baptiste Michel; Sigmar Stricker; Tom H Lindner; Peter Nürnberg; Kazuyuki Sugahara; Stefan Mundlos; Katrin Hoffmann
Journal:  Am J Hum Genet       Date:  2011-07-15       Impact factor: 11.025

4.  UGT1A6 genotype-related pharmacokinetics of deferiprone (L1) in healthy volunteers.

Authors:  Lie Michael George Limenta; Totsapol Jirasomprasert; Jeeranut Tankanitlert; Saovaros Svasti; Prapin Wilairat; Udom Chantharaksri; Suthat Fucharoen; Noppawan Phumala Morales
Journal:  Br J Clin Pharmacol       Date:  2008-03-03       Impact factor: 4.335

5.  The first aspartic acid of the DQxD motif for human UDP-glucuronosyltransferase 1A10 interacts with UDP-glucuronic acid during catalysis.

Authors:  Yan Xiong; Anne-Sisko Patana; Michael J Miley; Agnieszka K Zielinska; Stacie M Bratton; Grover P Miller; Adrian Goldman; Moshe Finel; Matt R Redinbo; Anna Radominska-Pandya
Journal:  Drug Metab Dispos       Date:  2007-11-29       Impact factor: 3.922

6.  Predicting reactivity to drug metabolism: beyond P450s-modelling FMOs and UGTs.

Authors:  Mario Öeren; Peter J Walton; Peter A Hunt; David J Ponting; Matthew D Segall
Journal:  J Comput Aided Mol Des       Date:  2020-06-12       Impact factor: 3.686

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.